A new study out of Oxford University suggests COVID-19 patients could be saved with the help of dexamethasone, an inexpensive and widely used steroid. If the findings bear out, it would be the first drug known to reduce deaths of severely ill COVID-19 patients. Briana Vannozzi asked Rutgers University professor of medicine and infectious diseases Dr. Martin Blaser if it’s the breakthrough we’ve been waiting for. To watch the interview.
Recent Posts
- Scientists Find Common Medications May Impact Gut Microbiome for Years.
- A surprising cause of some urinary tract infections: Contaminated meat.
- Scientists Discover How Leukemia Cells Evade Treatment.
- Researchers Track Characteristics of Firearm Owners Receiving Mental Health Treatment.
- Why the Collapse of Firearm Violence Prevention Is a Threat to U.S. Lives.
Categories
- Community (2,390)
- Covid (993)
- CTO Events (6)
- News (3,028)
- Pilots (21)